Exploration of a clinically characterized cohort, clinical study I, instead showed decreased CSF concentrations of AP2B1, CTSB, CTSF, LAMP1, LAMP2, and ubiquitin in PD compared to prodromal AD. This evidence concerns the gene CTSF and Parkinson disease.